PDL BioPharma, Inc. Total non-current liabilities

Total non-current liabilities of PDLI for past 10 years: annual, quarterly and twelve month trailing (TTM) including Total non-current liabilities growth rates and interactive chart.


Highlights and Quick Summary

  • Total non-current liabilities for the quarter ending June 29, 2020 was $64.4 Million (a -0.81% decrease compared to previous quarter)
  • Year-over-year quarterly Total non-current liabilities decreased by -65.51%
  • Annual Total non-current liabilities for 2019 was $77.1 Million (a -57.49% decrease from previous year)
  • Annual Total non-current liabilities for 2018 was $181 Million (a -11.09% decrease from previous year)
  • Annual Total non-current liabilities for 2017 was $204 Million (a -38.08% decrease from previous year)
Visit stockrow.com/PDLI for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical Total non-current liabilities of PDL BioPharma, Inc.

Most recent Total non-current liabilitiesof PDLI including historical data for past 10 years.

Interactive Chart of Total non-current liabilities of PDL BioPharma, Inc.

PDL BioPharma, Inc. Total non-current liabilities for the past 10 Years (both Annual and Quarterly)

(All values are in $ million)

Year Q1 Q2 Q3 Q4 Fiscal Year
2020 $64.42 $64.95
2019 $78.24 $186.79 $186.7 $186.43 $77.15
2018 $181.49 $198.37 $187.64 $206.33 $181.49
2017 $204.12 $206.72 $206.89 $199.59 $204.12
2016 $329.65 $340.7 $287.94 $283.91 $329.65
2015 $279.51 $330.06 $324.38 $319.44 $279.51
2014 $313.93 $316.22 $311.33 $305.39 $313.93
2013 $23.04 $167.5 $165.46 $337.7 $23.04
2012 $337.61 $333.08 $328.46 $329.1 $337.61
2011 $340.74 $340.2 $360.75 $272.95 $340.74
2010 $446.86 $352.83 $398.79 $446.86

Business Profile of PDL BioPharma, Inc.

Sector: Other
Industry: Other
PDL BioPharma, Inc. manages various patents in the United States and internationally. The company's patents cover humanization of antibodies. It also offers notes and other long-term receivables services, as well as engages in the equity investment activities. The company was formerly known as Protein Design Labs, Inc. and changed its name to PDL BioPharma, Inc. in 2006. PDL BioPharma, Inc. was founded in 1986 and is headquartered in Incline Village, Nevada.